Farms.com Home   News

CDC Reduces Support Price Of Skim Milk Powder

The Canadian Dairy Commission (CDC) has announced that it will be reducing the support price of skim milk powder effective March 1, 2015.
 
The support price will decrease from $6.4754 to $6.3109 per kg. The support price of butter will remain unchanged.
 
"This reduction follows a decrease in the cost of producing milk in Canada in the last year. This cost decrease can be seen mostly in feed, milk transportation, fuel, and interest paid" says Randy Williamson, Chairman of the CDC. "We are optimistic that this price reduction will help grow the demand for dairy products."
 
Support prices are the prices at which the CDC buys and sells butter and skim milk powder to balance seasonal changes in demand on the domestic market.
 
They are also used as references by provincial marketing boards to price industrial milk.
 
For dairy producers, this decrease in the support price should translate into a revenue decrease of 1.8% or $1.49 per hectolitre for industrial milk used to make products such as yogurt, cheese, and skim milk powder.
 
The CDC, a crown corporation created in 1966, helps design, implement, and administer policies and programs to address milk producer and processor needs.
 

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.